Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,998 DKK | -0.51% | -0.35% | -7.19% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.19% | 18.68B | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.00% | 22.19B | |
-16.16% | 21.33B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B | |
-21.14% | 8.63B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : HC Wainwright Downgrades Genmab to Neutral From Buy